The Quantellect read.As of Nov 19, 2026, 9 active firms cover AtriCure Inc: 7 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $48.00 to $68.00, a moderate spread. The average target of $58.13 sits 5% above the current $55.48. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 12% next, consensus EPS building from about $0.03 next quarter toward $0.46 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Buy
Strong Buy00%
Buy778%
Neutral222%
Sell00%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$58.13
+4.8% upside
Average target across 8 active firms as of Nov 19, 2026 vs $55.48 current
Highest Target$68.00
Average Target$58.13
Lowest Target$48.00
Detailed analyst forecasts for ATRC
Showing 1–11 of 11 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 7 of 9 active firms rate ATRC a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ATRC EPS & revenue forecast
EPS · NEXT QUARTER
$0.03
Range $-0.05 – $0.11 · 6 analysts
Next period, 6 analysts expect AtriCure Inc to earn $0.03 a share (range $-0.05 – $0.11), versus $0.00 a year earlier. Full-year consensus is $0.43, growing to $0.46 the year after.
REVENUE · NEXT QUARTER
$158.6M
Range $157.5M – $159.7M · 6 analysts · +13% YoY
Revenue is expected to reach $158.6M (range $157.5M – $159.7M), +13.0% year-over-year. Full-year consensus is $608.3M, rising to $682.3M next year.
Top analysts covering AtriCure Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ATRC.
#1
Ryan Zimmerman
BTIG · Rank #212
Buy
$63.00+13.6% to target
Overall win rate
37%
+ Follow
#2
Mike Matson
Needham · Rank #285
Buy
$64.00+15.4% to target
Overall win rate
36%
+ Follow
#3
William Plovanic
Canaccord Genuity · Rank #370
Buy
$55.00-0.9% to target
Overall win rate
38%
+ Follow
#4
Matt O'Brien
Piper Sandler · Rank #561
Buy
$60.00+8.1% to target
Overall win rate
25%
+ Follow
#5
MT
Marie Thibault
BTIG
Buy
$70.00+26.2% to target
Coverage
—
+ Follow
ATRC stock forecast FAQ
What is ATRC's average 12-month price target?+
The 8 active firms with a live target average $58.13 for AtriCure Inc over the next 12 months, ranging from a $68.00 high to a $48.00 low, as of Nov 19, 2026.
Is ATRC stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 9 active firms as of Nov 19, 2026, 7 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ATRC?+
The Street-high target is $68.00 (Citizens), and the Street-low is $48.00 (JP Morgan). The average of all 8 active-firm targets is $58.13.
How many active Wall Street firms cover ATRC?+
9 active firms have a recognized rating on AtriCure Inc as of Nov 19, 2026, and 8 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ATRC?+
Among analysts who currently cover ATRC, Ryan Zimmerman of BTIG has the strongest overall Quantellect track record (Rank #212). Their current call is Buy with a $63.00 target.
What is AtriCure Inc's projected EPS for next quarter?+
The consensus estimate is $0.03 per share (range $-0.05 – $0.11) across 6 analysts. Full-year EPS is projected at $0.43, rising to $0.46 the following year.
How much revenue is AtriCure Inc expected to report next quarter?+
Consensus revenue is $158.6M (range $157.5M – $159.7M). Full-year revenue is projected at $608.3M, growing to $682.3M next year.
Have analysts been upgrading or downgrading ATRC lately?+
As of Nov 19, 2026, 7 of 9 active firms rate ATRC a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ATRC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.